Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
MINNEAPOLIS--(BUSINESS WIRE)--Advanced Circulatory, makers of multiple medical devices and the pioneer of Perfusion on DemandTM (POD) therapy, announced today that the company has raised $2 million in bridge financing. The company will use the bridge funds to support the continued global commercialization of its ResQPOD® and ResQGARD® Impedance Threshold Devices (ITDs) as well as the launch and commercialization of its ResQCPR® System, which is currently pending regulatory approvals.
Help employers find you! Check out all the jobs and post your resume.
MINNEAPOLIS--(BUSINESS WIRE)--Advanced Circulatory, makers of multiple medical devices and the pioneer of Perfusion on DemandTM (POD) therapy, announced today that the company has raised $2 million in bridge financing. The company will use the bridge funds to support the continued global commercialization of its ResQPOD® and ResQGARD® Impedance Threshold Devices (ITDs) as well as the launch and commercialization of its ResQCPR® System, which is currently pending regulatory approvals.
Help employers find you! Check out all the jobs and post your resume.
